Patents Assigned to EpimAb Biotherapeutics, Inc.
  • Fabs-in-tandem immunoglobulin and uses thereof
    Patent number: 11421028
    Abstract: The present invention provides multivalent and multispecific binding proteins that are capable of binding two or more antigens, or two or more epitopes. The present invention also provides methods of making and using such multivalent and multispecific binding proteins, including methods of using such binding proteins for prevention or treatment of various diseases, or for detecting specific antigens in vitro or in vivo.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: August 23, 2022
    Assignee: EPIMAB BIOTHERAPEUTICS, INC.
    Inventor: Chengbin Wu
  • Fabs-in-tandem immunoglobulin and uses thereof
    Patent number: 10519251
    Abstract: The present invention provides multivalent and multispecific binding proteins that are capable of binding two or more antigens, or two or more epitopes. The present invention also provides methods of making and using such multivalent and multispecific binding proteins, including methods of using such binding proteins for prevention or treatment of various diseases, or for detecting specific antigens in vitro or in vivo.
    Type: Grant
    Filed: December 24, 2014
    Date of Patent: December 31, 2019
    Assignee: EpimAb Biotherapeutics, Inc.
    Inventor: Chengbin Wu
  • Fabs-in-tandem immunoglobulin and uses thereof
    Patent number: 10266608
    Abstract: The present invention provides multivalent and multispecific binding proteins that are capable of binding two or more antigens, or two or more epitopes. The present invention also provides methods of making and using such multivalent and multispecific binding proteins, including methods of using such binding proteins for prevention or treatment of various diseases, or for detecting specific antigens in vitro or in vivo.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: April 23, 2019
    Assignee: EpimAb Biotherapeutics, Inc.
    Inventor: Chengbin Wu